About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
MF Scheme SnapShots
Check out details of a particular scheme along with the latest NAV for various time periods. You can widen your search on the basis of the Fund House, Category and particular Scheme.
Nippon India Pharma Fund(G)-Direct Plan
 
Summary
Fund Name Nippon India Mutual Fund  
Scheme Name Nippon India Pharma Fund(G)-Direct Plan  
AMC Nippon Life India Asset Management Limited  
Type Open ended scheme  
Category Equity - Sectoral Fund - Pharma & Health Care  
Launch Date 01-Jan-13  
Fund Manager Sailesh Raj Bhan  
Face Value 10  
Custodian Deutsche Bank A.G.  
Net Assets (Rs. cr) 8080.97  
AMC Details
Nippon Life India Asset Management Limited
4th Floor, Tower A, Peninsula Business Park,
Ganapatrao Kadam Marg, Lower Parel (W)
Mumbai - 400 013
Phone : 022-68087000
Fax : 022-68087097
customercare@nipponindiaim.in
https://mf.nipponindiaim.com/
Registrar & Transfer Agent Details
KFin Technologies Limited
Selenium Building, Tower-B, Plot No 31 & 32
Financial District,Nanakramguda, Serilingampally
Hyderabad - 500 032
(040) 23312454 23320751 23320752
(040) 23311968
customercare@karvy.com
https://mfs.kfintech.com/
 
 
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.